Awards as PI
Program Type | Institution | Grant Title | Award Value |
---|---|---|---|
Disease Team Research I | Stanford University | iPS Cell-Based Treatment of Dominant Dystrophic Epidermolysis Bullosa | $11,039,208 |
Total: $11,039,208.00 |
Publications
- J Invest Dermatol 2011 Successful Investigational New Drug Preparation without Reinventing the Wheel. (PubMed: 21494234)
- Sci Transl Med 2014 Human COL7A1-corrected induced pluripotent stem cells for the treatment of recessive dystrophic epidermolysis bullosa. (PubMed: 25429056)